EMUNKITUG
UNII WLY9W5E6NW

Substance Identification & Data

This profile provides standardized clinical and technical data for Emunkitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WLY9W5E6NW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2916519-48-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WLY9W5E6NW

CAS Registry Number

2916519-48-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EMUNKITUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C187143

National Cancer Institute reference terminology for clinical and research data.

INN ID

13090

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Emunkitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EMUNKITUG

Common Names & Synonyms

EMUNKITUG [INN]

H-GAMMA1 HEAVY CHAIN HUMANIZED (1-448) (VH (HOMO SAPIENS IGHV1-46*04 (83.5%) -(IGHD) -IGHJ6*01 (92.3%) Q120>T (110), CDR-IMGT (8.8.11) (26-33.51-58.97-107)) (1-118) -HOMO SAPIENS IGHG1*03 (100%) G1M3, NG1M1 CH1 R120, CH3 E12, M14 (CH1 R120 (215) (119-216), HINGE 1-15 (217-231), CH2 (232-341), CH3 E12 (357), M14 (359) (342-446), CHS (447-448)) (119-448)), (221-213')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-213') (VKAPPA (HOMO SAPIENS IGKV1-9*01 (81.1%) -IGKJ2*01 (90.9%) Q120>S (99), CDR-IMGT (5.3.9) (27'-31'.49'-51'.88'-96')) (1'-106') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (152'), V101 (190')) (107'-213')); DIMER (227-227'':230-230'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA ANTINEOPLASTIC

IMMUNOGLOBULIN G1, ANTI-(HUMAN TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY PROTEIN TNFRSF1B) (HUMAN-MUS MUSCULUS MONOCLONAL HFB200301 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HFB200301 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TNFRSF1B (TUMOR NECROSIS FACTOR RECEPTOR (TNFR) SUPERFAMILY MEMBER 1B, TNFR2, TNFR TYPE II, P75, CD120B)), HUMANIZED MONOCLONAL ANTIBODY, AGONIST

Technical Codes

HFB200301

HFB-200301

External Clinical & Regulatory Resources

Previous UNIIWLY5DY586E

Next UNIIWLZ3BA9R26